[ad_1]

Currently, Phase III trials of the AZD1222 are being conducted in Brazil on thousands of volunteers to understand the safety and efficacy of the vaccine candidate. On the other hand, Serum Institute of India, which is the largest vaccine manufacturer of the world by volume, has teamed with UK drugmaker AstraZeneca to manufacturer 1 billion doses of COVID vaccine.

Adar Poonawalla, CEO of SII told PTI, “At present, we are working on the AstraZeneca Oxford vaccine which is undergoing phase III clinical trials. In addition to this, we will also start human trials in India in August 2020. Based on the current situation and most recent updates on the clinical trials, we are hoping that the AstraZeneca Oxford vaccine will be available towards the end of this year.”

[ad_2]

Source link